| |
|
| |
 |
|
| Joseph C. Cook, Jr. |
|
| Peter M. Hecht, Ph.D. |
|
| George Conrades |
|
| Stephen C. Knight, M.D. |
| Stephen C. Knight, M.D. is president of Fidelity Biosciences, a unit of Fidelity Investments. Prior to joining Fidelity in 2003, Dr. Knight was president and chief operating officer for EPIX Medical, Inc. He also served EPIX as chief financial officer and senior vice president of business development. For the six years before joining EPIX, Dr. Knight worked at Arthur D. Little Inc., primarily as a senior consultant specializing in mergers and acquisitions in the pharmaceutical industry. Dr. Knight currently serves as chairman of the board of directors for Veritas Medicine and EnVivo Pharmaceuticals. He also serves on the board of directors of U.S. Genomics. Previously he was a director at Pharmos, Inc. |
|
| Terrance G. McGuire |
|
| Gina Bornino Miller |
|
| Bryan E. Roberts, Ph.D. |
|
| David Shaw |
|
| Christopher T. Walsh, Ph.D. |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
